Global Medical REIT Inc. (NYSE:GMRE) Chairman Jeffrey Busch bought 2,630 shares of the company’s stock in a transaction dated Tuesday, November 14th. The shares were acquired at an average cost of $9.29 per share, for a total transaction of $24,432.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Shares of Global Medical REIT Inc. (NYSE:GMRE) traded down $0.05 during midday trading on Friday, hitting $9.34. The stock had a trading volume of 72,617 shares, compared to its average volume of 132,116. The stock has a market capitalization of $200.52, a price-to-earnings ratio of 23.92, a price-to-earnings-growth ratio of 3.05 and a beta of -49.42. Global Medical REIT Inc. has a twelve month low of $7.12 and a twelve month high of $10.25. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.22 and a current ratio of 0.22.
COPYRIGHT VIOLATION NOTICE: “Global Medical REIT Inc. (GMRE) Chairman Buys $24,432.70 in Stock” was first posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international copyright legislation. The correct version of this news story can be viewed at https://sportsperspectives.com/2017/11/19/global-medical-reit-inc-gmre-chairman-buys-24432-70-in-stock.html.
A number of analysts have recently issued reports on GMRE shares. Zacks Investment Research lowered Global Medical REIT from a “hold” rating to a “sell” rating in a research report on Tuesday, November 7th. FBR & Co reaffirmed a “buy” rating and set a $10.50 target price (up from $10.00) on shares of Global Medical REIT in a research report on Monday, September 18th. B. Riley reaffirmed a “buy” rating on shares of Global Medical REIT in a research report on Wednesday, November 1st. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $12.00 target price on shares of Global Medical REIT in a research report on Friday, September 1st. Finally, DA Davidson lowered Global Medical REIT from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $11.00 to $10.00 in a research report on Tuesday, August 22nd. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $10.60.
Global Medical REIT Company Profile
Receive News & Ratings for Global Medical REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.